Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | -1.93%149.68B | 52.33%152.63B | 100.2B |
| Net profit before non-cash adjustment | 13.41%74.33B | 228.33%65.54B | --19.96B |
| Total adjustment of non-cash items | -11.92%81.43B | 9.49%92.44B | --84.43B |
| -Depreciation and amortization | -2.23%72.1B | 4.79%73.75B | --70.38B |
| -Reversal of impairment losses recognized in profit and loss | 217.56%1.25B | --393M | --0 |
| -Share of associates | 64.00%-99M | 44.78%-275M | ---498M |
| -Disposal profit | -285.80%-4.15B | -33.83%2.23B | --3.37B |
| -Other non-cash items | -24.59%12.33B | 46.25%16.35B | --11.18B |
| Changes in working capital | -13.56%-6.08B | -27.68%-5.36B | ---4.19B |
| -Change in receivables | 46.59%-1.72B | 42.34%-3.21B | ---5.57B |
| -Change in inventory | -186.02%-720M | 156.10%837M | ---1.49B |
| -Change in payables | 99.38%-15M | -214.22%-2.4B | --2.1B |
| -Provision for loans, leases and other losses | 150.45%2.22B | 10.31%888M | --805M |
| -Changes in other current assets | -117.29%-3.52B | ---1.62B | ---- |
| -Changes in other current liabilities | -1,626.80%-2.34B | 513.51%153M | ---37M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | 2.49%-11.97B | -18.43%-12.27B | -10.36B |
| Interest received (cash flow from operating activities) | |||
| Tax refund paid | -167.67%-14.17B | -219.57%-5.29B | -1.66B |
| Other operating cash inflow (outflow) | -2M | 0 | -1M |
| Operating cash flow | -8.53%123.54B | 53.18%135.07B | --88.18B |
| Investing cash flow | |||
| Capital expenditures | ---- | --0 | ---192.12B |
| Net PPE purchase and sale | 9.40%-94.12B | -27.39%-103.89B | ---81.55B |
| Net investment product transactions | -9,868.00%-2.49B | ---25M | ---- |
| Net changes in other investments | 93.02%7.11B | -7.93%3.68B | --4B |
| Investing cash flow | 10.70%-89.5B | 62.83%-100.23B | ---269.67B |
| Financing cash flow | |||
| Net issuance payments of debt | -51.74%-32.09B | -112.55%-21.15B | --168.49B |
| Cash dividends paid | -60.00%-18.59B | -25.00%-11.62B | ---9.3B |
| Net other fund-raising expenses | 31.52%-265M | -3.20%-387M | ---375M |
| Financing cash flow | -53.66%-50.94B | -120.88%-33.15B | --158.81B |
| Net cash flow | |||
| Beginning cash position | 1.89%90.67B | -20.31%88.98B | --111.66B |
| Current changes in cash | -1,104.34%-16.9B | 107.42%1.68B | ---22.68B |
| Cash adjustments other than cash changes | ---- | ---- | --1M |
| End cash Position | -18.64%73.76B | 1.89%90.67B | --88.98B |
| Free cash flow | -75.55%7.56B | 116.66%30.93B | ---185.66B |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |